Czech Marcin
Narodowy Instytut Zdrowia, Polskie Towarzystwo Farmakoekonomiczne.
Pol Merkur Lekarski. 2004 May;16 Suppl 1:16-9.
Following international examples, economic evaluation of health care programmes is starting to play an increasing role in Poland. Applying the broadest view, an economic evaluation is defined as the comparative analysis of alternative courses of action in terms of their costs and consequences. This definition includes economic evaluation of prescribed drugs by the term pharmacoeconomics. Pharmacoeconomics can be defined by the study of economic implications of drug usage. From a practical point of view, pharmacoeconomics is a part of health economics, the aim of which is to optimize pharmacotherapy through rational drug management. The role of pharmacoeconomic research is to identify measure and compare the resources consumed and corresponding costs with consequences in the form of clinical, humanistic and economic outcomes of pharmaceutical products and services used. The results of these studies serve as scientific evidence for decision making. The Polish Chapter of the International Society for Pharmacoeconomics and Research (ISPOR) is the main scientific organization operating in the field of pharmacoeconomics in Poland.
效仿国际上的范例，医疗保健项目的经济评估在波兰正开始发挥越来越重要的作用。从最宽泛的角度来看，经济评估被定义为对不同行动方案在成本和后果方面的比较分析。这个定义通过药物经济学这一术语涵盖了处方药的经济评估。药物经济学可以被定义为对药物使用的经济影响的研究。从实际角度来看，药物经济学是卫生经济学的一部分，其目的是通过合理的药物管理来优化药物治疗。药物经济学研究的作用是识别、衡量并比较所消耗的资源以及相应成本与以药品和服务的临床、人文和经济成果形式呈现的后果。这些研究结果为决策提供科学依据。国际药物经济学与结果研究协会（ISPOR）波兰分会是波兰在药物经济学领域运作的主要科学组织。
